SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Marcus Aurelius Synthetic CCD — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientMarcus Aurelius
Date of birth0121-04-25
IdentifiersMRN HR-AC004-SYN-TD; SSN (made up) 000-04-1213
Document date2026-11-01
AuthorOctavia Ashworth-Nnamdi, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

New patient visit for chronic epigastric and lower chest pain after meals, poor appetite and poor sleep: cardiac assessment first, review of an opium-containing remedy, and gastroenterology referral for endoscopy. Concerns: He has had pain in his chest and stomach after meals for more than a year and wants to know whether his heart is sound; He sleeps badly and is tired, and must stay clear-headed for his work; He has taken the herbal paste for years and does not want to be judged for it, or made to stop it before he is ready. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Opium-containing compounded herbal paste (an electuary of honey, many herbs and poppy, from an overseas supplier; not prescribed and not regulated, so its morphine content is unknown), about a pea-sized amount (roughly 0.5 g) by mouth at bedtime most nights for about six years, and now and then in the morning before a long dayAbout 0.5 g at bedtime most nights; occasionally a second amount in the morningOral route0168-05-01 to 0174-06-06completedS
Calcium carbonate 500 mg chewable tablet, one or two tablets as needed for heartburn, no more than six a day, until the endoscopyOne or two tablets as needed, at least four hours apart; no more than six a dayOral route0174-05-12 to 0174-05-19completedS
Polyethylene glycol 3350 powder, 17 g dissolved in a glass of water by mouth once daily as needed for constipation17 g once daily as neededOral route0174-05-12activeS
Naloxone 4 mg nasal spray, one spray into one nostril for suspected opioid overdose, repeated in 2 to 3 minutes in the other nostril if there is no response; call 911One spray for suspected overdose; repeat every 2 to 3 minutes if neededNasal route0174-05-12activeS
Omeprazole 20 mg delayed-release capsule, one capsule by mouth 30 to 60 minutes before breakfast for eight weeks, for erosive esophagitisOne capsule each morning before breakfast for eight weeksOral route0174-05-19 to 0174-07-14completedS
Omeprazole 20 mg delayed-release capsule, one capsule by mouth before breakfast on days after heartburn returns (on-demand therapy after the eight-week course)One capsule on a day with heartburn; no more than one a dayOral route0174-07-14activeS
Opium-containing compounded herbal paste (unregulated, strength unknown), about 0.5 g by mouth at bedtime on alternate nights, a reduction he chose and made himselfAbout 0.5 g at bedtime every other nightOral route0174-06-06 to 0174-07-28completedS
Opium-containing compounded herbal paste (unregulated, strength unknown), a smaller amount, about 0.3 g, by mouth at bedtime on about two nights a week, a further reduction he choseAbout 0.3 g at bedtime on about two nights a weekOral route0174-07-28activeS
Acetaminophen 500 mg oral tablet, one or two tablets by mouth every six hours as needed for fever or aches, no more than 3 g a dayOne or two tablets every six hours as needed; no more than six a dayOral route0174-07-07 to 0174-07-28completedS

Procedures

ProcedureDatesStatusEvidence
Twelve-lead electrocardiogram at intake: sinus rhythm 76, normal intervals, no ST or T-wave changes, no Q waves0174-05-12 to 0174-05-12completedS
CT coronary angiography with coronary calcium scoring (prospectively ECG-gated): coronary calcium score 0, no plaque or stenosis (CAD-RADS 0)0174-05-19 to 0174-05-19completedS
Upper endoscopy (esophagogastroduodenoscopy) under moderate sedation0174-05-19 to 0174-05-19completedS
Gastric biopsies (two antrum, one incisura, two body; updated Sydney protocol) with a rapid urease test0174-05-19 to 0174-05-19completedS
Advance care planning conversation, about 20 minutes0174-07-28 to 0174-07-28completedS

Immunizations

DateVaccineStatusEvidence
0174-07-28Pneumococcal conjugate vaccine, 20-valent (PCV20), single dose for an adult aged 50 or oldercompletedS
0174-07-28Recombinant zoster vaccine (RZV), dose 1 of 2completedS
0174-07-28Hepatitis B vaccine (HepB-CpG), dose 1 of 2completedS
0174-08-25Hepatitis B vaccine (HepB-CpG), dose 2 of 2completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
In boyhood (year not recorded)As a boy, study so hard that it impaired his health (no illness named)D (CLM-0015)
Before the first book of the Meditations, written about 171 to 175 CEBlood-spitting and giddiness, for which he credits remedies shown to him in dreams (cause not recorded in the cited source)D (CLM-0008)
During his reign (year not recorded)Frail in body; stomach and chest 'in bad condition'; ate little and only at night; took theriac daily (cause not recorded in the cited source)D (CLM-0006, CLM-0009)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
He has had pain in his chest and stomach after meals for more than a year and wants to know whether his heart is soundactiveS
He sleeps badly and is tired, and must stay clear-headed for his workactiveS
He has taken the herbal paste for years and does not want to be judged for it, or made to stop it before he is readyactiveS

Assessment

Most recent measures: Hemoglobin [Mass/volume] in Blood 14.6 on 0174-05-12; MCV [Entitic mean volume] in Red Blood Cells by Automated count 90 on 0174-05-12; Leukocytes [#/volume] in Blood by Automated count 6.2 on 0174-05-12; Platelets [#/volume] in Blood by Automated count 238 on 0174-05-12; Sodium [Moles/volume] in Serum or Plasma 139 on 0174-05-12; Potassium [Moles/volume] in Serum or Plasma 4.3 on 0174-05-12; Urea nitrogen [Mass/volume] in Serum or Plasma 14 on 0174-05-12; Creatinine [Mass/volume] in Serum or Plasma 0.95 on 0174-05-12; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 169)/1.73 sq M 96 on 0174-05-12; Glucose [Mass/volume] in Serum or Plasma 92 on 0174-05-12; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22 on 0174-05-12; Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 on 0174-05-12; Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 72 on 0174-05-12; Bilirubin.total [Mass/volume] in Serum or Plasma 0.6 on 0174-05-12; Albumin [Mass/volume] in Serum or Plasma 4.1 on 0174-05-12; Lipase [Enzymatic activity/volume] in Serum or Plasma 32 on 0174-05-12; Hemoglobin A1c/Hemoglobin.total in Blood 5.4 on 0174-05-12; Cholesterol [Mass/volume] in Serum or Plasma 205 on 0174-05-12; Cholesterol in HDL [Mass/volume] in Serum or Plasma 48 on 0174-05-12; Triglyceride [Mass/volume] in Serum or Plasma 120 on 0174-05-12; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 133 on 0174-05-12; Lipoprotein a [Moles/volume] in Serum or Plasma 38 on 0174-05-12; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 on 0174-08-25; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 3 on 0174-08-25; Total score [AUDIT-C] 2 on 0174-07-28; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 on 0174-07-28 [S]

Strengths and supports: Family: has children; his family lives far from the field site. Supports: a few trusted colleagues and his own discipline [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Burning and pressing pain in the upper abdomen and lower chest after meals, for more than a year and worse over three months, with poor appetite, waking at night with pain and a sour taste, and a 3 kg weight loss; not brought on by exertion; normal ECG; cardiac and peptic causes to be excludedresolvedconfirmed R10.13S — Synthetic presenting concern at the index visit, superseded by the diagnosis at endoscopy; its pattern echoes the stomach and chest complaints and the pain with food that Dio describes (D).
Gastroesophageal reflux disease with erosive esophagitis, Los Angeles grade B, and a 2 cm sliding hiatal hernia; Helicobacter pylori negative on biopsy; coronary disease excluded by CT coronary angiography; synthetic modern diagnosis for his documented stomach and chest complaintsactiveconfirmed K21.00S — Synthetic modern diagnosis; the cause of his real complaints is unknown and no historical diagnosis is made.
Daily use of an unregulated opium-containing herbal remedy for about six years, for stomach pain and sleep; opioid use disorder criteria not met (one DSM-5-TR criterion, restlessness and poor sleep when he stopped it); expected physiological dependence; constipation and possibly slowed gastric emptying from the opioidactiveconfirmed F11.90S — Synthetic modern finding anchored to the theriac he took (D); no opioid use disorder or addiction is attributed to him (the claim is disputed, R).
Chronic insomnia disorder for more than a year, with waking from night pain and trouble returning to sleep; Insomnia Severity Index 17 (moderate)activeconfirmed G47.00S — Synthetic modern finding anchored to Galen's account of his sleeplessness without the poppy juice (D, possible).
Sustained strain of command: leads a large organization through a long field assignment far from home, with long days and little restactiveconfirmed Z56.6S — Synthetic work strain anchored to his documented years on campaign (D).
Constipation from the opioid in his remedy: hard stools every two or three daysactiveconfirmed K59.03S — Synthetic finding at intake.
COVID-19, mild (rapid antigen test positive), without breathlessness or low oxygen; antiviral treatment offered and declined; resolvedresolvedconfirmed U07.1S — Synthetic intercurrent illness; not a claim about the Antonine Plague or about any illness in his lifetime.

Results

DateMeasureValueUnitReference rangeFlagProvenance
0174-05-12Hemoglobin [Mass/volume] in Blood14.6g/dL13.2-17.1 g/dLNormalS
0174-05-12MCV [Entitic mean volume] in Red Blood Cells by Automated count90fL80-100 fLNormalS
0174-05-12Leukocytes [#/volume] in Blood by Automated count6.210*3/uL4-11 10*3/uLNormalS
0174-05-12Platelets [#/volume] in Blood by Automated count23810*3/uL150-400 10*3/uLNormalS
0174-05-12Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
0174-05-12Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
0174-05-12Urea nitrogen [Mass/volume] in Serum or Plasma14mg/dL7-20 mg/dLNormalS
0174-05-12Creatinine [Mass/volume] in Serum or Plasma0.95mg/dL0.7-1.3 mg/dLNormalS
0174-05-12Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 169)/1.73 sq M96mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
0174-05-12Glucose [Mass/volume] in Serum or Plasma92mg/dL70-139 mg/dLNormalS
0174-05-12Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma22U/L7-55 U/LNormalS
0174-05-12Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L8-48 U/LNormalS
0174-05-12Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma72U/L40-129 U/LNormalS
0174-05-12Bilirubin.total [Mass/volume] in Serum or Plasma0.6mg/dL0.1-1.2 mg/dLNormalS
0174-05-12Albumin [Mass/volume] in Serum or Plasma4.1g/dL3.5-5 g/dLNormalS
0174-05-12Lipase [Enzymatic activity/volume] in Serum or Plasma32U/L13-60 U/LNormalS
0174-05-12Hemoglobin A1c/Hemoglobin.total in Blood5.4%Below 5.7% is normal; 5.7 to 6.4% prediabetesNormalS
0174-05-12Cholesterol [Mass/volume] in Serum or Plasma205mg/dL<=199 mg/dLHighS
0174-05-12Cholesterol in HDL [Mass/volume] in Serum or Plasma48mg/dL>=40 mg/dLNormalS
0174-05-12Triglyceride [Mass/volume] in Serum or Plasma120mg/dL<=149 mg/dLNormalS
0174-05-12Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation133mg/dL<=129 mg/dLHighS
0174-05-12Lipoprotein a [Moles/volume] in Serum or Plasma38nmol/L125 nmol/L or more adds to cardiovascular riskNormalS
0174-05-12Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]8{score}S
0174-05-12Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]6{score}S
0174-05-12Total score [AUDIT-C]3{score}S
0174-06-16Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S
0174-08-25Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
0174-08-25Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]3{score}S
0174-07-28Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
0174-07-28Total score [AUDIT-C]2{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
0174-05-12Body height172cmS
0174-05-12Body weight63kgS
0174-05-12Body mass index (BMI) [Ratio]21.3kg/m2S
0174-05-12Systolic blood pressure124mm[Hg]S
0174-05-12Diastolic blood pressure78mm[Hg]S
0174-05-12Heart rate76/minS
0174-05-12Respiratory rate14/minS
0174-05-12Body temperature36.6CelS
0174-05-12Oxygen saturation in Arterial blood by Pulse oximetry98%S
0174-05-19Body height172cmS
0174-05-19Body weight63.2kgS
0174-05-19Body mass index (BMI) [Ratio]21.4kg/m2S
0174-05-19Systolic blood pressure122mm[Hg]S
0174-05-19Diastolic blood pressure76mm[Hg]S
0174-05-19Heart rate74/minS
0174-05-19Respiratory rate14/minS
0174-05-19Body temperature36.5CelS
0174-05-19Oxygen saturation in Arterial blood by Pulse oximetry98%S
0174-06-16Body height172cmS
0174-06-16Body weight64kgS
0174-06-16Body mass index (BMI) [Ratio]21.6kg/m2S
0174-06-16Systolic blood pressure120mm[Hg]S
0174-06-16Diastolic blood pressure76mm[Hg]S
0174-06-16Heart rate72/minS
0174-06-16Respiratory rate14/minS
0174-06-16Body temperature36.6CelS
0174-06-16Oxygen saturation in Arterial blood by Pulse oximetry98%S
0174-08-25Body height172cmS
0174-08-25Body weight65kgS
0174-08-25Body mass index (BMI) [Ratio]22kg/m2S
0174-08-25Systolic blood pressure118mm[Hg]S
0174-08-25Diastolic blood pressure76mm[Hg]S
0174-08-25Heart rate70/minS
0174-08-25Respiratory rate14/minS
0174-08-25Body temperature36.6CelS
0174-08-25Oxygen saturation in Arterial blood by Pulse oximetry98%S
0174-07-07Body height172cmS
0174-07-07Body weight63.6kgS
0174-07-07Body mass index (BMI) [Ratio]21.5kg/m2S
0174-07-07Systolic blood pressure118mm[Hg]S
0174-07-07Diastolic blood pressure74mm[Hg]S
0174-07-07Heart rate94/minS
0174-07-07Respiratory rate16/minS
0174-07-07Body temperature38.3CelS
0174-07-07Oxygen saturation in Arterial blood by Pulse oximetry97%S
0174-07-28Body height172cmS
0174-07-28Body weight64.4kgS
0174-07-28Body mass index (BMI) [Ratio]21.8kg/m2S
0174-07-28Systolic blood pressure118mm[Hg]S
0174-07-28Diastolic blood pressure76mm[Hg]S
0174-07-28Heart rate70/minS
0174-07-28Respiratory rate14/minS
0174-07-28Body temperature36.6CelS
0174-07-28Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
0174-05-12New patient visit for chronic epigastric and lower chest pain after meals, poor appetite and poor sleep: cardiac assessment first, review of an opium-containing remedy, and gastroenterology referral for endoscopyfinishedS
0174-05-19Gastroenterology consultation with upper endoscopy and biopsy, review of the CT coronary angiogram, diagnosis of erosive esophagitis, and start of omeprazolefinishedS
0174-06-16Five-week review: reflux symptoms on omeprazole, biopsy results, sleep therapy, and the remedyfinishedS
0174-08-25Fifteen-week review after the eight-week omeprazole course: on-demand therapy, sleep, the remedy, and moodfinishedS
0174-07-07Same-day sick visit for mild COVID-19 while taking an opium-containing remedyfinishedS
0174-07-28Periodic adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Cardiac assessment first: twelve-lead ECG today; a structured estimate of the chance of coronary disease; no troponin, because the pain is chronic and there is no acute episode; CT coronary angiography within a week, chosen over stress testing because it excludes both obstructive and non-obstructive plaque and informs the cholesterol decision; call 911 for chest pain at rest lasting more than a few minutes, or pain with breathlessness, sweating or faintingcompletedGL-AHA-CP-2021, GL-CMID-2026S
Gastroenterology consultation for upper endoscopy within one week, with gastric biopsies for Helicobacter pylori, to find the cause of the chest and epigastric pain after the cardiac assessment and to advise on treatment; no acid-suppressing drug before the endoscopy, with an antacid as neededcompletedGL-ACG-GERD-2022, GL-ACG-DYS-2017, GL-ACG-HP-2024S
Respectful review of the opium-containing remedy: what it is, why he takes it, and what it does for him; a DSM-5-TR assessment; a prescription drug monitoring program check; a urine drug test with his consent, explained as part of care; naloxone at home; no alcohol, sleep medicines or other sedatives on the same night; never more than his usual amount; stored closed and out of reach; how opioids slow the gut; no forced or abrupt taper, and any reduction his own choice, made slowly; reviewed at every visit, with the 988 Suicide & Crisis LifelinecompletedGL-CDC-OPIOID-2022S
Chronic insomnia: cognitive behavioral therapy for insomnia (CBT-I) with the clinic's behavioral sleep clinician, six sessions, with a sleep diary, sleep restriction, stimulus control and work on racing thoughts at night; Insomnia Severity Index at intake and at each review; no hypnotic or sedating antihistamine, which would add to the opioidcompletedGL-AASM-INS-2021, GL-ACP-INS-2016S
Strain of command and mood: PHQ-9 and GAD-7 at intake and at follow-up; protected time for meals and sleep, decisions delegated after a set hour, and his evening writing kept; counselling if scores risecompletedGL-USPSTF-DEP-2023S
Constipation: polyethylene glycol as needed, fluids and fiber; review as the remedy changescompletedGL-CDC-OPIOID-2022S
Reflux esophagitis: omeprazole 20 mg 30 to 60 minutes before breakfast for eight weeks, then a trial off with omeprazole on demand; the evening meal at least three hours before lying down, the head of the bed raised, and less wine at night; no repeat endoscopy for grade B esophagitis; esophageal manometry and reflux monitoring off therapy if symptoms persist or swallowing becomes difficultcompletedGL-ACG-GERD-2022S
Mild COVID-19: rest, fluids and acetaminophen; honey for cough; no codeine or dextromethorphan cough medicine, sedating antihistamine or sleep aid while he takes the opium-containing remedy, and no more of the remedy than usual; naloxone at hand; antiviral treatment offered and declined after a shared decision; stay away from others until fever-free for 24 hours without medicine and improving, then added precautions for five days; call 911 for breathlessness, chest pain, confusion or blue lips, and return for oxygen saturation below 94% on a home oximetercompletedGL-CDC-RESP-2024, GL-CDC-COVIDTX-2025, GL-IDSA-COVID, GL-CDC-OPIOID-2022S
Colorectal cancer screening: colonoscopy ordered for the first quiet stretch of his assignment, with a split-dose bowel preparation and two extra days of polyethylene glycol beforehand because the opioid slows the bowel, and no remedy the night before; fecal immunochemical testing each year if he prefers not to have colonoscopycompletedGL-USPSTF-CRC-2021S

Goals

GoalTargetStatusOutcomeProvenance
A cardiac cause of the chest pain excluded within two weeks0174-05-19completedNormal ECG at intake; CT coronary angiography one week later: calcium score 0 and no plaqueS
Chest and stomach pain after meals controlled, with appetite and weight returning0174-08-25completedPain gone on omeprazole; occasional mild heartburn after late meals on on-demand therapy; weight up 2 kgS
Insomnia Severity Index below 8 within four months0174-08-25completedInsomnia Severity Index 7 after six sessions of CBT-IS
The remedy used as safely as he can: naloxone at home, never with alcohol or sleep medicines, and decisions about it his own0174-08-25activeNaloxone at home; no alcohol on nights he takes it; by his own choice now about two nights a weekS

Functional Status

Mental Status

Structured synthetic safety assessment on 0174-05-12: current ideation absent, intent absent, plan absent. Outpatient care; the 988 Suicide & Crisis Lifeline; naloxone at home; the remedy kept in a closed container out of others' reach and never taken with alcohol or sleep medicines; review at every visit [S]